バイオテクノロジー機器市場：製品別、エンドユーザー別-2025-2030年の世界予測

バイオテクノロジー機器市場は、2023年に241億9,000万米ドルと評価され、2024年には264億9,000万米ドルに達すると予測され、CAGR 9.84%で成長し、2030年には466億7,000万米ドルに達すると予測されています。

バイオテクノロジー機器市場には、バイオテクノロジーの研究開発および応用に不可欠な機器やツールが幅広く含まれています。これらには、ゲノミクス、プロテオミクス、細胞生物学、診断検査用の機器が含まれます。これらの機器の必要性は、ヘルスケア、製薬、農業において、疾病診断、創薬、遺伝子組み換えなどの複雑な生物学的課題に対処するための先端技術への需要が高まっていることに起因しています。バイオテクノロジー機器は、シーケンシング、イメージング、クロマトグラフィー、分光学など様々な用途で利用されており、最終用途は医療研究機関、製薬会社、研究所などです。

市場の成長は、分子生物学技術の進歩、バイオテクノロジー研究への資金提供の増加、個別化医療への需要の高まりなどの要因に影響されます。新たなビジネスチャンスは、コスト効率に優れ、ポータブルでハイスループットな装置の開発や、データ解析能力を高めるためのAIや機械学習の統合にあります。また、いくつかの生物学的製剤の特許切れを背景に、生物学的製剤やバイオシミラーの開発に対応する機器市場も拡大しています。

同市場における課題としては、高度な機器に関連する高コスト、複雑な規制環境、これらの複雑な機器を操作するための高度に熟練した人材の必要性などが挙げられます。さらに、技術革新のペースが速いため、既存の装置がすぐに古くなり、陳腐化のリスクがあります。

機器の小型化、ラボオンチップ技術の開発、バイオセンサーの感度と特異性の向上などの分野で技術革新が進んでいます。装置のコスト削減、バイオテクノロジーアッセイの精度とスピードの向上に焦点を当てた調査は、さらなる成長機会を提供します。

バイオテクノロジー機器市場はダイナミックで競争が激しく、絶え間ない進歩と研究開発の重視が特徴です。規制状況を乗り切り、進化するエンドユーザーの需要に対応し、技術革新を活用できる企業は、成長の可能性を活用し、市場での存在感を維持するのに有利な立場にあります。

市場力学：急速に進化するバイオテクノロジー機器市場の主要市場インサイトを公開

バイオテクノロジー機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 疾病の継続的な増加と効果的な治療の必要性
  • 携帯型ポイントオブケア診断機器の採用拡大
  • 各国におけるヘルスケア支出とインフラの改善
• 市場抑制要因
  • バイオテクノロジー機器の導入に伴う初期コストの高さ
• 市場機会
  • ラボオートメーション機器の進歩
  • ゲノム研究プロジェクトや新興企業への投資の増加
• 市場の課題
  • 厳しい規制要件と検証プロセス

ポーターの5つの力：バイオテクノロジー機器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオテクノロジー機器市場における外部からの影響の把握

外部マクロ環境要因は、バイオテクノロジー機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオテクノロジー機器市場における競合情勢の把握

バイオテクノロジー機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオテクノロジー機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオテクノロジー機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオテクノロジー機器市場における成功への道筋を描く

バイオテクノロジー機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 疾病の蔓延と効果的な治療法の必要性の継続的な増加
    • ポータブルなポイントオブケア診断機器の採用増加
    • 経済全体でヘルスケア費支出とインフラの改善
  • 抑制要因
    • バイオテクノロジー機器の導入に伴う初期コストの高さ
  • 機会
    • ラボ自動化機器の進歩
    • ゲノム調査プロジェクトとスタートアップへの新たな投資
  • 課題
    • 厳格な規制要件と検証プロセス
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオテクノロジー機器市場：製品別

• バイオリアクター
• 遠心分離機
• 電気泳動
• 免疫測定
• インキュベーター
• 液体クロマトグラフィー
• 質量分析
• 次世代シーケンシング
• 分光光度計

第7章 バイオテクノロジー機器市場：エンドユーザー別

• バイオテクノロジーおよびバイオ医薬品企業
• 臨床調査機関（CRO）
• 政府機関および学術機関

第8章 南北アメリカのバイオテクノロジー機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のバイオテクノロジー機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのバイオテクノロジー機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Alcon Scientific
• Azenta Life Sciences
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Bruker Corporation
• Danaher Corporation
• Endress+Hauser Group Services AG
• F. Hoffmann-La Roche Ltd.
• GE HealthCare Technologies Inc.
• HORIBA, Ltd.
• Hudson Robotics
• Illumina, Inc.
• JASCO
• Lumentum Holdings Inc.
• Merck KGaA
• Oxford Nanopore Technologies PLC
• PerkinElmer U.S. LLC
• Qiagen GmbH
• Quest Diagnostics Incorporated
• Sartorius AG
• Shimadzu Corporation
• Siemens Healthcare GmbH
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Waters Corporation

LIST OF FIGURES

• FIGURE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET RESEARCH PROCESS
• FIGURE 2. BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOTECHNOLOGY INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOTECHNOLOGY INSTRUMENTATION MARKET DYNAMICS
• TABLE 7. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. AUSTRALIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CHINA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. INDIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. INDONESIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. JAPAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. MALAYSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. PHILIPPINES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. SINGAPORE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. SOUTH KOREA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. TAIWAN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. THAILAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. VIETNAM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. DENMARK BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. EGYPT BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. FINLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. FRANCE BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. GERMANY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. ISRAEL BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. ITALY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. NETHERLANDS BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. NIGERIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. NORWAY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. POLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. QATAR BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. RUSSIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SAUDI ARABIA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH AFRICA BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. SPAIN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. SWEDEN BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. SWITZERLAND BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. TURKEY BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. UNITED ARAB EMIRATES BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. UNITED KINGDOM BIOTECHNOLOGY INSTRUMENTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. BIOTECHNOLOGY INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 108. BIOTECHNOLOGY INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

The Biotechnology Instrumentation Market was valued at USD 24.19 billion in 2023, expected to reach USD 26.49 billion in 2024, and is projected to grow at a CAGR of 9.84%, to USD 46.67 billion by 2030.

The biotechnology instrumentation market encompasses a wide array of devices and tools essential for the research, development, and application of biotechnology. These include instruments for genomics, proteomics, cell biology, and diagnostic testing. The necessity of these instruments stems from the growing demand for advanced technologies in healthcare, pharmaceuticals, and agriculture to address complex biological challenges, such as disease diagnosis, drug discovery, and genetic modification. Biotech instruments are utilized in various applications, such as sequencing, imaging, chromatography, and spectroscopy, with end-use in medical research institutions, pharmaceutical companies, and laboratories.

Market growth is influenced by factors such as advancements in molecular biology techniques, increased funding for biotech research, and the rising demand for personalized medicine. Emerging opportunities lie in the development of cost-effective, portable, and high-throughput devices, as well as integrating AI and machine learning to enhance data analysis capabilities. There is also a growing market for instruments that cater to the development of biologics and biosimilars, driven by the expiration of patents for several biologic drugs.

Challenges in the market include high costs associated with advanced instrumentation, the intricate regulatory environment, and the need for highly skilled personnel to operate these complex devices. Furthermore, the rapid pace of technological change can outdate existing instruments quickly, posing a risk of obsolescence.

Innovation is ripe in fields such as miniaturization of devices, development of lab-on-a-chip technologies, and enhancement of biosensor sensitivity and specificity. Research focusing on reducing instrument costs and improving the accuracy and speed of biotechnological assays offers further growth opportunities.

The biotech instrumentation market is dynamic and competitive, characterized by continuous advancements and a strong emphasis on research and development. Companies that can navigate regulatory landscapes, cater to evolving end-user demands, and leverage technological innovations are well-positioned to capitalize on growth potential and sustain their market relevance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Continuous rise in prevalence of diseases and need for effective treatments
  • Growing adoption of portable point-of-care diagnostic devices
  • Improved healthcare spending and infrastructure across economies
• Market Restraints
  • Initial high costs associated with implementation of biotechnology instruments
• Market Opportunities
  • Growing advancements in lab automation instruments
  • Emerging investments in genomic research projects and startups
• Market Challenges
  • Stringent regulatory requirements and validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Instrumentation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Instrumentation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Instrumentation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Instrumentation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Instrumentation Market

A detailed market share analysis in the Biotechnology Instrumentation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Instrumentation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Instrumentation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Instrumentation Market

A strategic analysis of the Biotechnology Instrumentation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Instrumentation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alcon Scientific, Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Bruker Corporation, Danaher Corporation, Endress+Hauser Group Services AG, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., HORIBA, Ltd., Hudson Robotics, Illumina, Inc., JASCO, Lumentum Holdings Inc., Merck KGaA, Oxford Nanopore Technologies PLC, PerkinElmer U.S. LLC, Qiagen GmbH, Quest Diagnostics Incorporated, Sartorius AG, Shimadzu Corporation, Siemens Healthcare GmbH, Tecan Trading AG, Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biotechnology Instrumentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bioreactors, Centrifuges, Electrophoresis, Immunoassay, Incubators, Liquid Chromatography, Mass Spectrometry, Next Generation Sequencing, and Spectrophotometers.
• Based on End-User, market is studied across Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), and Government & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Continuous rise in prevalence of diseases and need for effective treatments
    • 5.1.1.2. Growing adoption of portable point-of-care diagnostic devices
    • 5.1.1.3. Improved healthcare spending and infrastructure across economies
  • 5.1.2. Restraints
    • 5.1.2.1. Initial high costs associated with implementation of biotechnology instruments
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing advancements in lab automation instruments
    • 5.1.3.2. Emerging investments in genomic research projects and startups
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements and validation processes
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biotechnology Instrumentation Market, by Product

• 6.1. Introduction
• 6.2. Bioreactors
• 6.3. Centrifuges
• 6.4. Electrophoresis
• 6.5. Immunoassay
• 6.6. Incubators
• 6.7. Liquid Chromatography
• 6.8. Mass Spectrometry
• 6.9. Next Generation Sequencing
• 6.10. Spectrophotometers

7. Biotechnology Instrumentation Market, by End-User

• 7.1. Introduction
• 7.2. Biotechnology & Biopharmaceutical Companies
• 7.3. Clinical Research Organizations (CROs)
• 7.4. Government & Academic Institutes

8. Americas Biotechnology Instrumentation Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biotechnology Instrumentation Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Instrumentation Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Alcon Scientific
• 4. Azenta Life Sciences
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. bioMerieux SA
• 8. Bruker Corporation
• 9. Danaher Corporation
• 10. Endress+Hauser Group Services AG
• 11. F. Hoffmann-La Roche Ltd.
• 12. GE HealthCare Technologies Inc.
• 13. HORIBA, Ltd.
• 14. Hudson Robotics
• 15. Illumina, Inc.
• 16. JASCO
• 17. Lumentum Holdings Inc.
• 18. Merck KGaA
• 19. Oxford Nanopore Technologies PLC
• 20. PerkinElmer U.S. LLC
• 21. Qiagen GmbH
• 22. Quest Diagnostics Incorporated
• 23. Sartorius AG
• 24. Shimadzu Corporation
• 25. Siemens Healthcare GmbH
• 26. Tecan Trading AG
• 27. Thermo Fisher Scientific Inc.
• 28. Waters Corporation